Dan Gibson, PhD
Chief Technology Officer
Dan Gibson is the CTO of Codex DNA. He oversees Codex DNA’s world-class R&D team and sets the technical vision for the company.
Dan is the inventor of the Gibson Assembly® method, which has over 4,000 citations in scientific literature. Dan is regarded as a luminary in his field. He and his team are consistently pioneering new ways to advance the field of synthetic biology and pushing boundaries in the disciplines of personalized medicine, antibody therapy development, agriculture, and industrial materials.
Dan and his team formed the foundational technology that drives the BioXp™ system and the digital to biologic converter (DBC). They continue to develop new, cutting-edge tools for whole-genome design, synthesis and assembly, and activation. To learn more about the work of Dan’s team and the DBC view his 2018 Ted talk.
Prior to Codex DNA, Dan was Vice President of DNA Technology at Synthetic Genomics, where he spearheaded efforts to develop a rapid approach for producing viral genes used in pandemic vaccine production in 2013, and he led the team that developed the first synthesized minimal cell in the world in 2016. Prior to Synthetic Genomics, Dan spent more than six years at the J. Craig Ventner Institute, where he co-led the team that constructed the first synthetic bacterial genome in 2008 and the first synthetic cell in 2010.
Dr. Gibson earned his PhD in Molecular Biology from the University of Southern California. Before earning his PhD, he earned his Bachelor’s degree in Biological Sciences from the State University of New York at Buffalo.